Dentists in Califon, NJ Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Thomas F Golden, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7 Windy Heights Rd, Califon, NJ 07830 Phone: 908-832-5165 |
Dr. Rudolph R Leidl, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 87 W Valley Brook Rd, Califon, NJ 07830 Phone: 908-876-9772 |
Dr. Joseph G. Schweighardt Iii, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3 Sliker Rd, Califon, NJ 07830 Phone: 908-832-2300 Fax: 908-832-6286 |
John David Hirce, DMD MSD Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 3a Sliker Road, Califon, NJ 07830 Phone: 908-832-2461 Fax: 908-832-2576 |
Mitchel Jay Feldman, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3 Sliker Road, Califon, NJ 07830 Phone: 908-832-7500 |
News Archive
Easy Breathe offers sleep apnea therapy device, AirSense CPAP
Easy Breathe, the fastest growing online sleep apnea shopping destination, today announced that it now offers the revolutionary AirSense CPAPs by ResMed.
A discreet option for pain relief in the workplace
Employers say that back pain-related problems account for over 100 million lost workdays a year. In a cutthroat economy with unemployment at a record high, this is especially disconcerting news. Employees cannot afford to risk losing their jobs to other candidates while stuck home in bed recuperating. With 80% of Americans experiencing back pain in their lifetime, back issues have serious implications on job security and can negatively affect even the most dedicated employee's performance abilities and job attendance.
Boehringer Ingelheim's Prazaxa receives Japanese approval for stroke prevention in AF patients
The Ministry of Health, Labour and Welfare in Japan today approved dabigatran etexilate, Boehringer Ingelheim's novel, oral direct thrombin inhibitor under the brand name Prazaxa for the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation marking the first approval of a novel oral anticoagulant in the Asia-Pacific region and specifically Japan in nearly 50 years.
Emerald BioStructures engineers new allosteric small molecule modulators of the PDE4 enzyme
Emerald BioStructures (formerly deCODE biostructures) announced today a publication in the December 27, 2009 advance online issue of Nature Biotechnology, detailing the application of structure-based drug design (SBDD) to engineer new allosteric small molecule modulators of the enzyme phosphodiesterase-4 (PDE4), with reduced side effects. According to the paper, the researchers established the structural basis of PDE4 regulation through crystal structures of the PDE4 regulatory domain in contact with small molecules.
› Verified 3 days ago
Dentists
Clinical Social Workers
Counselors
Pharmacists
Psychologists